Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome

Journal of Immunology

Volumn 179, Issue 7, 2007, Pages 4929-4938

  Bombardieri, Michele ^a   Barone, Francesca ^b   Humby, Frances ^a   Kelly, Stephen ^a   McGurk, Mark ^c   Morgan, Peter ^c   Challacombe, Stephen ^c   De Vita, Salvatore ^d   Valesini, Guido ^b   Spencer, Jo ^c   Pitzalis, Costantino ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE DEAMINASE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL POPULATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ECTOPIC TISSUE; FEMALE; FOLLICULAR DENDRITIC CELL; HUMAN; HUMAN TISSUE; LYMPHATIC SYSTEM DISEASE; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PAROTID GLAND; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIALOADENITIS; SJOEGREN SYNDROME;

ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CELL DIFFERENTIATION; CYTIDINE DEAMINASE; DENDRITIC CELLS, FOLLICULAR; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; PROTEIN TRANSPORT; RNA, MESSENGER; SIALADENITIS; SJOGREN'S SYNDROME;

EID: 43349091335     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.7.4929     Document Type: Article

References (44)

1. Voulgarelis, M., and H. M. Moutsopoulos. 2003. Lymphoproliferation in autoimmunity and Sjogren's syndrome. Curr. Rheumatol. Rep. 5: 317-323.
2. Stott, D. I., F. Hiepe, M. Hummel, G. Steinhauser, and C. Berek. 1998. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease: the salivary glands of patients with Sjogren's syndrome. J. Clin. Invest. 102: 938-946.
3. Routsias, J. G., A. G. Tzioufas, and H. M. Moutsopoulos. 2004. The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. Clin. Chim. Acta 340: 1-25.
4. Manser, T. 2004. Textbook germinal centers? J. Immunol. 172: 3369-3375.
5. Maclennan, I. C., K. M. Toellner, A. F. Cunningham, K. Serre, D. M. Sze, E. Zuniga, M. C. Cook, and C. G. Vinuesa. 2003. Extrafollicular antibody responses. Immunol. Rev. 194: 8-18.
6. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
7. Muramatsu, M., V. S. Sankaranand, S. Anant, M. Sugai, K. Kinoshita, N. O. Davidson, and T. Honjo. 1999. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274: 18470-18476.
8. Marafioti, T., M. Jones, F. Facchetti, T. C. Diss, M. Q. Du, P. G. Isaacson, M. Pozzobon, S. A. Pileri, A. J. Strickson, S. Y. Tan, et al. 2003. Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood 102: 2868-2876.
9. Cattoretti, G., M. Buttner, R. Shaknovich, E. Kremmer, B. Alobeid, and G. Niedobitek. 2006. Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells. Blood 107: 3967-3975.
10. Moldenhauer, G., S. W. Popov, B. Wotschke, S. Bruderlein, P. Riedl, N. Fissolo, R. Schirmbeck, O. Ritz, P. Moller, and F. Leithauser. 2006. AID expression identifies interfollicular large B cells as putative precursors of mature B-cell malignancies. Blood 107: 2470-2473.
11. Barone, F., M. Bombardieri, A. Manzo, M. C. Blades, P. R. Morgan, S. J. Challacombe, G. Valesini, and C. Pitzalis. 2005. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum. 52: 1773-1784.
12. Bombardieri, M., F. Barone, V. Pittoni, C. Alessandri, P. Conigliaro, M. C. Blades, R. Priori, I. B. McInnes, G. Valesini, and C. Pitzalis. 2004. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res. Ther. 6: R447-R456.
13. Salomonsson, S., M. V. Jonsson, K. Skarstein, K. A. Brokstad, P. Hjelmstrom, M. Wahren-Herlenius, and R. Jonsson. 2003. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome. Arthritis Rheum. 48: 3187-3201.
14. Aloisi, F., and R. Pujol-Borrell. 2006. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6: 205-217.
15. Drayton, D. L., S. Liao, R. H. Mounzer, and N. H. Ruddle. 2006. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7: 344-353.
16. Jacobi, A. M., A. Hansen, O. Kaufmann, A. Pruss, G. R. Burmester, P. E. Lipsky, and T. Dorner. 2002. Analysis of immunoglobulin light chain rearrangements in the salivary gland and blood of a patient with Sjogren's syndrome. Arthritis Res. 4: R4-R15.
17. Royer, B., D. Cazals-Hatem, J. Sibilia, F. Agbalika, J. M. Cayuela, T. Soussi, F. Maloisel, J. P. Clauvel, J. C. Brouet, and X. Mariette. 1997. Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 90: 766-775.
18. Bahler, D. W., and S. H. Swerdlow. 1998. Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjogren's syndrome) begin as nonmalignant antigen-selected expansions. Blood 91: 1864-1872.
19. Mariette, X. 1999. Lymphomas in patients with Sjogren's syndrome: review of the literature and physiopathologic hypothesis. Leuk. Lymphoma 33: 93-99.
20. Bahler, D. W., J. A. Miklos, and S. H. Swerdlow. 1997. Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood 89: 3335-3344.
21. Du, M., T. C. Diss, C. Xu, H. Peng, P. G. Isaacson, and L. Pan. 1996. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia 10: 1190-1197.
22. Vitali, C., S. Bombardieri, R. Jonsson, H. M. Moutsopoulos, E. L. Alexander, S. E. Carsons, T. E. Daniels, P. C. Fox, R. I. Fox, S. S. Kassan, et al. 2002. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61: 554-558.
23. Chisholm, D. M., and D. K. Mason. 1968. Labial salivary gland biopsy in Sjogren's disease. J. Clin. Pathol. 21: 656-660.
24. Liu, Y. J., J. Xu, O. de Bouteiller, C. L. Parham, G. Grouard, O. Djossou, B. Saint-Vis, S. Lebecque, J. Banchereau, and K. W. Moore. 1997. Follicular dendritic cells specifically express the long CR2/CD21 isoform. J. Exp. Med. 185: 165-170.
25. Bacon, C. M., M. Q. Du, and A. Dogan. 2006. MALT lymphoma: a practical guide for pathologists. J. Clin. Pathol. 60: 361-372.
26. Gellrich, S., S. Rutz, A. Borkowski, S. Golembowski, E. Gromnica-Ihle, W. Sterry, and S. Jahn. 1999. Analysis of V(H)-D-J(H) gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjogren's syndrome. Arthritis Rheum. 42: 240-247.
27. William, J., C. Euler, S. Christensen, and M. J. Shlomchik. 2002. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297: 2066-2070.
28. William, J., C. Euler, and M. J. Shlomchik. 2005. Short-lived plasmablasts dominate the early spontaneous rheumatoid factor response: differentiation pathways, hypermutating cell types, and affinity maturation outside the germinal center. J. Immunol. 174: 6879-6887.
29. Pasqualucci, L., R. Guglielmino, J. Houldsworth, J. Mohr, S. Aoufouchi, R. Polakiewicz, R. S. Chaganti, and R. Dalla-Favera. 2004. Expression of the AID protein in normal and neoplastic B cells. Blood 104: 3318-3325.
30. Brar, S. S., M. Watson, and M. Diaz. 2004. Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. J. Biol. Chem. 279: 26395-26401.
31. Deutsch, A. J., A. Aigelsreiter, P. B. Staber, A. Beham, W. Linkesch, C. Guelly, R. I. Brezinschek, M. Fruhwirth, W. Emberger, M. Buettner, et al. 2006. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation. Blood 109: 3500-3504.
32. Harris, N. L., E. S. Jaffe, H. Stein, P. M. Banks, J. K. Chan, M. L. Cleary, G. Delsol, C. Wolf-Peeters, B. Falini, K. C. Gatter, et al. 1994. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361-1392.
33. Spencer, J., T. Finn, K. A. Pulford, D. Y. Mason, and P. G. Isaacson. 1985. The human gut contains a novel population of B lymphocytes which resemble marginal zone cells. Clin. Exp. Immunol. 62: 607-612.
34. Gasparotto, D., S. De Vita, R. De, V. A. Marzotto, G. De Marchi, C. A. Scott, A. Gloghini, G. Ferraccioli, and M. Boiocchi. 2003. Extrasalivary lymphoma development in Sjogren's syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering. Arthritis Rheum. 48: 3181-3186.
35. Willenbrock, K., B. Jungnickel, M. L. Hansmann, and R. Kuppers. 2005. Human splenic marginal zone B cells lack expression of activation-induced cytidine deaminase. Eur. J. Immunol. 35: 3002-3007.
36. Hsu, H. C., Y. Wu, P. Yang, Q. Wu, G. Job, J. Chen, J. Wang, M. A. Accavitti-Loper, W. E. Grizzle, R. H. Carter, and J. D. Mountz. 2007. Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J. Immunol. 178: 5357-5365.
37. Dunn-Walters, D. K., P. G. Isaacson, and J. Spencer. 1995. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J. Exp. Med. 182: 559-566.
38. Tierens, A., J. Delabie, L. Michiels, P. Vandenberghe, and C. Wolf-Peeters. 1999. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood 93: 226-234.
39. Qin, Y., A. Greiner, M. J. Trunk, B. Schmausser, M. M. Ott, and H. K. Muller-Hermelink. 1995. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood 86: 3528-3534.
40. Chapman, C. J., D. K. Dunn-Walters, F. K. Stevenson, T. Hussell, P. G. Isaacson, and J. Spencer. 1996. Sequence analysis of immunoglobulin variable region genes that encode autoantibodies expressed by lymphomas of mucosa associated lymphoid tissue. Clin. Mol. Pathol. 49: M29-M32.
41. Hussell, T., P. G. Isaacson, J. E. Crabtree, and J. Spencer. 1996. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J. Pathol. 178: 122-127.
42. Bende, R. J., W. M. Aarts, R. G. Riedl, D. de Jong, S. T. Pals, and C. J. van Noesel. 2005. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J. Exp. Med. 201: 1229-1241.
43. Martin, T., J. C. Weber, H. Levallois, N. Labouret, A. Soley, S. Koenig, A. S. Korganow, and J. L. Pasquali. 2000. Salivary gland lymphomas in patients with Sjogren's syndrome may frequently develop from rheumatoid factor B cells. Arthritis Rheum. 43: 908-916.
44. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.